These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 34146618)

  • 1. Obesity Without Metabolic Abnormality and Incident CKD: A Population-Based British Cohort Study.
    Wang J; Niratharakumar K; Gokhale K; Tahrani AA; Taverner T; Thomas GN; Dasgupta I
    Am J Kidney Dis; 2022 Jan; 79(1):24-35.e1. PubMed ID: 34146618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between weight status, metabolic syndrome, and chronic kidney disease among middle-aged and elderly Chinese.
    Wang Y; Sun B; Sheng LT; Pan XF; Zhou Y; Zhu J; Li X; Yang K; Guo K; Zhang X; He M; Yang H; Wu T; Pan A
    Nutr Metab Cardiovasc Dis; 2020 Oct; 30(11):2017-2026. PubMed ID: 32826134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolically healthy obesity and risk of incident CKD.
    Hashimoto Y; Tanaka M; Okada H; Senmaru T; Hamaguchi M; Asano M; Yamazaki M; Oda Y; Hasegawa G; Toda H; Nakamura N; Fukui M
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):578-83. PubMed ID: 25635035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolically Healthy Obesity and Development of Chronic Kidney Disease: A Cohort Study.
    Chang Y; Ryu S; Choi Y; Zhang Y; Cho J; Kwon MJ; Hyun YY; Lee KB; Kim H; Jung HS; Yun KE; Ahn J; Rampal S; Zhao D; Suh BS; Chung EC; Shin H; Pastor-Barriuso R; Guallar E
    Ann Intern Med; 2016 Mar; 164(5):305-12. PubMed ID: 26857595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic subtypes and risk of mortality in normal weight, overweight, and obese individuals with CKD.
    Hanks LJ; Tanner RM; Muntner P; Kramer H; McClellan WM; Warnock DG; Judd SE; Gutiérrez OM;
    Clin J Am Soc Nephrol; 2013 Dec; 8(12):2064-71. PubMed ID: 24178980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity, Metabolic Abnormality, and Progression of CKD.
    Yun HR; Kim H; Park JT; Chang TI; Yoo TH; Kang SW; Choi KH; Sung S; Kim SW; Lee J; Oh KH; Ahn C; Han SH;
    Am J Kidney Dis; 2018 Sep; 72(3):400-410. PubMed ID: 29728317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic abnormalities, but not obesity per se, associated with chronic kidney disease in a Taiwanese population.
    Chen HY; Lu FH; Chang CJ; Wang RS; Yang YC; Chang YF; Wu JS
    Nutr Metab Cardiovasc Dis; 2020 Mar; 30(3):418-425. PubMed ID: 31744713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Transition in Metabolic Health and Obesity on the Incident Chronic Kidney Disease: A Nationwide Cohort Study.
    Cho YK; Lee J; Kim HS; Park JY; Lee WJ; Kim YJ; Jung CH
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31967306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of chronic kidney disease in a metabolically healthy obese population.
    Jung CH; Lee MJ; Kang YM; Hwang JY; Kim EH; Park JY; Kim HK; Lee WJ
    Kidney Int; 2015 Oct; 88(4):843-50. PubMed ID: 26108064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic phenotypes of obese, overweight, and normal weight individuals and risk of chronic kidney disease: a systematic review and meta-analysis.
    Alizadeh S; Esmaeili H; Alizadeh M; Daneshzad E; Sharifi L; Radfar H; Radaei MK
    Arch Endocrinol Metab; 2019 Jul; 63(4):427-437. PubMed ID: 31365625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in obese metabolic phenotypes over time and risk of incident chronic kidney disease.
    Nam KH; Yun HR; Joo YS; Kim J; Lee S; Lee C; Park KS; Park JT; Chang TI; Kang EW; Yoo TH; Kang SW; Han SH
    Diabetes Obes Metab; 2018 Dec; 20(12):2778-2791. PubMed ID: 29971899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolically healthy overweight/obesity and cancer risk: A representative cohort study in Taiwan.
    Lin CJ; Chang YC; Hsu HY; Tsai MC; Hsu LY; Hwang LC; Chien KL; Yeh TL
    Obes Res Clin Pract; 2021; 15(6):564-569. PubMed ID: 34782258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between Metabolic Phenotypes of Body Fatness and Incident Stroke: A Prospective Cohort Study of Chinese Community Residents.
    Tang M; Zhao Q; Yi K; Wu Y; Xiang Y; Zaid M; Cui S; Su X; Yu Y; Zhao G; Jiang Y
    Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body mass index and early kidney function decline in young adults: a longitudinal analysis of the CARDIA (Coronary Artery Risk Development in Young Adults) study.
    Grubbs V; Lin F; Vittinghoff E; Shlipak MG; Peralta CA; Bansal N; Jacobs DR; Siscovick DS; Lewis CE; Bibbins-Domingo K
    Am J Kidney Dis; 2014 Apr; 63(4):590-7. PubMed ID: 24295611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Nested Case-Control Study of Metabolically Defined Body Size Phenotypes and Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Murphy N; Cross AJ; Abubakar M; Jenab M; Aleksandrova K; Boutron-Ruault MC; Dossus L; Racine A; Kühn T; Katzke VA; Tjønneland A; Petersen KE; Overvad K; Quirós JR; Jakszyn P; Molina-Montes E; Dorronsoro M; Huerta JM; Barricarte A; Khaw KT; Wareham N; Travis RC; Trichopoulou A; Lagiou P; Trichopoulos D; Masala G; Krogh V; Tumino R; Vineis P; Panico S; Bueno-de-Mesquita HB; Siersema PD; Peeters PH; Ohlsson B; Ericson U; Palmqvist R; Nyström H; Weiderpass E; Skeie G; Freisling H; Kong SY; Tsilidis K; Muller DC; Riboli E; Gunter MJ
    PLoS Med; 2016 Apr; 13(4):e1001988. PubMed ID: 27046222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses' Health Study): 30 year follow-up from a prospective cohort study.
    Eckel N; Li Y; Kuxhaus O; Stefan N; Hu FB; Schulze MB
    Lancet Diabetes Endocrinol; 2018 Sep; 6(9):714-724. PubMed ID: 29859908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study.
    Foster MC; Hwang SJ; Larson MG; Lichtman JH; Parikh NI; Vasan RS; Levy D; Fox CS
    Am J Kidney Dis; 2008 Jul; 52(1):39-48. PubMed ID: 18440684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic obesity phenotypes and chronic kidney disease: a cross-sectional study from the RaNCD cohort study.
    Jam SA; Moloudpour B; Najafi F; Darbandi M; Pasdar Y
    BMC Nephrol; 2022 Jul; 23(1):233. PubMed ID: 35778682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined effect of body mass index and metabolic status on the risk of prevalent and incident chronic kidney disease: a systematic review and meta-analysis.
    Zhang J; Jiang H; Chen J
    Oncotarget; 2017 May; 8(22):35619-35629. PubMed ID: 27579531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular risk of metabolically healthy obesity in two european populations: Prevention potential from a metabolomic study.
    Wei D; González-Marrachelli V; Melgarejo JD; Liao CT; Hu A; Janssens S; Verhamme P; Van Aelst L; Vanassche T; Redon J; Tellez-Plaza M; Martin-Escudero JC; Monleon D; Zhang ZY
    Cardiovasc Diabetol; 2023 Apr; 22(1):82. PubMed ID: 37029406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.